ArticleJTCVS open2025
The clinical and financial impact of new-onset atrial fibrillation after coronary bypass grafting: From indexed procedure to long-term follow-up.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: New-onset postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) is common. Additional information regarding long-term clinical and financial outcomes is important. This statewide analysis compares periprocedural and long-term outcomes between patients with and without POAF. Methods: Data on patients who underwent isolated CABG from 2013 to 2021 without atrial fibrillation (AF) history from a statewide Society of Thoracic Surgeons database (N = 18,377) were merged with the state health services database. Patients with POAF (n = 4656) were compared with those without POAF (n = 13,721). Outcomes were incidence and cost of readmissions, examined with χ Results: The incidence of POAF was 25% (male = 26% vs female = 24%, Conclusions: POAF remains common after CABG, with greater cost and risk-adjusted morbidity reported. Follow-up data reveal a significant number of patients continue to be impacted by AF. This study suggests targeted discharge planning and surveillance for patients with POAF to improve long-term outcomes and reduce cost of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.